Clinical Trial Update: Evaluation of Abbreviated Versus Conventional Course of Dabigatran Etexilate Before Electric Cardioversion in Patients With Atrial Fibrillation (RE-SOUND Study) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating an abbreviated versus conventional course of dabigatran etexilate prior to electric cardioversion in atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)

Snippet

Sponsor: Ural State Medical University | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN